Bioinspired Pyrano[2,3-f]chromen-8-ones: Ring C-Opened Analogues of Calanolide A: Synthesis and Anti-HIV-1 Evaluation
-
Published:2024-01-11
Issue:1
Volume:9
Page:44
-
ISSN:2313-7673
-
Container-title:Biomimetics
-
language:en
-
Short-container-title:Biomimetics
Author:
Khalymbadzha Igor A.1, Fatykhov Ramil F.1, Butorin Ilya I.1ORCID, Sharapov Ainur D.1ORCID, Potapova Anastasia P.1, Muthipeedika Nibin Joy1, Zyryanov Grigory V.1, Melekhin Vsevolod V.12ORCID, Tokhtueva Maria D.1ORCID, Deev Sergey L.1, Kukhanova Marina K.3, Mochulskaya Nataliya N.1, Tsurkan Mikhail V.4ORCID
Affiliation:
1. Department of Organic and Biomolecular Chemistry, Ural Federal University, 620002 Yekaterinburg, Russia 2. Department of Medical Biology and Genetics, Ural State Medical University, 620028 Yekaterinburg, Russia 3. Engelhardt Institute of Molecular Biology, 119991 Moscow, Russia 4. Leibniz Institute of Polymer Research Dresden, 01069 Dresden, Germany
Abstract
We have designed and synthesized a series of bioinspired pyrano[2,3-f]coumarin-based Calanolide A analogs with anti-HIV activity. The design of these new calanolide analogs involved incorporating nitrogen heterocycles or aromatic groups in lieu of ring C, effectively mimicking and preserving their bioactive properties. Three directions for the synthesis were explored: reaction of 5-hydroxy-2,2-dimethyl-10-propyl-2H,8H-pyrano[2,3-f]chromen-8-one with (i) 1,2,4-triazines, (ii) sulfonylation followed by Suzuki cross-coupling with (het)aryl boronic acids, and (iii) aminomethylation by Mannich reaction. Antiviral assay of the synthesized compounds showed that compound 4 has moderate activity against HIV-1 on enzymes and poor activity on the cell model. A molecular docking study demonstrates a good correlation between in silico and in vitro HIV-1 reverse transcriptase (RT) activity of the compounds when docked to the nonnucleoside RT inhibitor binding site, and alternative binding modes of the considered analogs of Calanolide A were established.
Funder
Russian Science Foundation
Reference49 articles.
1. (2023, December 22). HIV and AIDS. Available online: https://www.who.int/news-room/fact-sheets/detail/hiv-aids. 2. Andrade, H.B., Shinotsuka, C.R., da Silva, I.R.F., Donini, C.S., Yeh Li, H., de Carvalho, F.B., do Brasil, P.E.A.A., Bozza, F.A., and Japiassu, A.M. (2017). Highly active antiretroviral therapy for critically ill HIV patients: A systematic review and metaanalysis. PLoS ONE, 12. 3. Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends;Zhan;J. Med. Chem.,2016 4. Discovery and Development of Anti-HIV Therapeutic Agents: Progress Towards Improved HIV Medication;Maeda;Curr. Top. Med. Chem.,2019 5. Hu, S., Chen, J., Cao, J.-X., Zhang, S.-S., Gu, S.-X., and Chen, F.-E. (2023). Quinolines and isoquinolines as HIV-1 inhibitors: Chemical structures, action targets, and biological activities. Bioorg. Chem., 136.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|